Experimental browser for the Atmosphere
Adjuvant hyperthermic intraperitoneal chemotherapy (HIPEC) did not significantly improve the locoregional recurrence rate, disease free-survival, and overall survival in patients with locally advanced colon cancer
May 18, 2025, 8:16 AM
{
"text": "Adjuvant hyperthermic intraperitoneal chemotherapy (HIPEC) did not significantly improve the locoregional recurrence rate, disease free-survival, and overall survival in patients with locally advanced colon cancer",
"$type": "app.bsky.feed.post",
"langs": [
"en"
],
"reply": {
"root": {
"cid": "bafyreiayvx4xsxxcuik6adouaezsgsyhvqnuyclpnoagxm2pdzwuenv2te",
"uri": "at://did:plc:yuomq2vsledkrl7flskqteeo/app.bsky.feed.post/3lpgmippxqk2k"
},
"parent": {
"cid": "bafyreiayvx4xsxxcuik6adouaezsgsyhvqnuyclpnoagxm2pdzwuenv2te",
"uri": "at://did:plc:yuomq2vsledkrl7flskqteeo/app.bsky.feed.post/3lpgmippxqk2k"
}
},
"createdAt": "2025-05-18T08:16:00.769Z"
}